Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an acquired immune-mediated inflammatory disorder of the peripheral nervous system. The disorder is sometimes called chronic relapsing polyneuropathy. CIDP is related to Guillain-Barré syndrome and sometimes considered the chronic counterpart of that acute disease. The pathologic hallmark of the disease is loss of the myelin sheath (the fatty covering that protects nerve fibers) of the peripheral nerves.
Chronic inflammatory demyelinating polyneuropathy presents with numerous symptoms including skin numbness, tingling, pain, progressive muscle weakness, loss of deep tendon reflexes (areflexia), fatigue, and abnormal sensations. The likelihood of progression of the disease is high.
Many specialists believe that, as a result of lack of awareness of CIDP, this disease is under-recognized and under-treated, which is very unfortunate, as early diagnosis and treatment are important in preventing irreversible axonal loss and improving functional recovery.
Dr. Katz’ practice is fully equipped with the necessary electrodiagnostic apparatus, which allows her to accurately and early diagnose this condition. She also provides treatment for CIDP in her Infusion Center according to her proprietary clinical protocols.